(5Z)-5-{[3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one

Catalog No. :
ACPUKZ350
CAS No. :
882218-76-0
Molecular Formula :
C21H17N3O3S2
Molecular Weight :
423.52

IUPAC Name:(Z)-5-((3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

(5Z)-5-{[3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$309.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-5-{[3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
IUPAC Name(Z)-5-((3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
MDL No.MFCD03617807
Molecular FormulaC21H17N3O3S2
Molecular Weight423.52
SMILESO=C1NC(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(OC)C(OC)=C4)=S
InChI KeyRHKLMTBEZZYLFD-WQRHYEAKSA-N
Synonym(5Z)-5-[[3-(3,4-dimethoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one;4-Thiazolidinone, 5-[[3-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-2-thioxo-
CAS No.882218-76-0

Synthetic Route by SureRoute

1. ACPUKZ350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACADET348 route compound structure diagram
    ACADET348141-84-4 In Stock
  4. Then
  5. ACPUKZ350 route product structure diagram
    ACPUKZ350882218-76-0
Inquiry

2. ACPUKZ350 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTFR361 route compound structure diagram
    ACLTFR361122775-35-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUKZ350 route product structure diagram
    ACPUKZ350882218-76-0
Inquiry

Comments (0)